Neurogene Inc.
NGNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$36 | -$55 | -$51 |
| Dep. & Amort. | $3 | $3 | $3 | $1 |
| Deferred Tax | $0 | -$0 | $0 | $0 |
| Stock-Based Comp. | $8 | $1 | $1 | $1 |
| Change in WC | -$6 | -$4 | -$3 | $2 |
| Other Non-Cash | -$1 | -$16 | $1 | $1 |
| Operating Cash Flow | -$71 | -$51 | -$53 | -$46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$2 | -$18 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$198 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $74 | $5 | $0 | $0 |
| Other Inv. Act. | $0 | $21 | $0 | $0 |
| Investing Cash Flow | -$125 | $26 | -$2 | -$18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | $0 |
| Stock Issued | $190 | $92 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | $0 | $67 | $51 |
| Financing Cash Flow | $184 | $92 | $67 | $51 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$12 | $67 | $11 | -$14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $149 | $82 | $71 | $84 |
| End Cash | $137 | $149 | $82 | $71 |
| Free Cash Flow | -$71 | -$52 | -$55 | -$65 |